Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
Portfolio Pulse from Avi Kapoor
Wall Street's most accurate analysts recommend holding three high-yielding health care stocks: Gilead Sciences, Pfizer, and Bristol-Myers Squibb. These stocks offer dividend yields over 3% and have received mixed ratings from top analysts.
July 29, 2024 | 1:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bristol-Myers Squibb has a 4.76% dividend yield. Analysts have mixed ratings with price targets ranging from $45 to $52. The company recently posted better-than-expected quarterly earnings.
Bristol-Myers Squibb's better-than-expected quarterly earnings are likely to positively impact the stock in the short term. The strong dividend yield further supports a positive outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Pfizer has a 5.46% dividend yield. Analysts have mixed ratings with price targets ranging from $28 to $30. The European Commission recently approved DURVEQTIX for hemophilia B treatment.
Pfizer's recent approval of DURVEQTIX by the European Commission is a positive development, likely to boost investor confidence. Combined with a high dividend yield, this news may have a positive short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEUTRAL IMPACT
Gilead Sciences has a 4.00% dividend yield. Analysts have mixed ratings with price targets ranging from $70 to $74. Recent 5-year data supports Biktarvy as a long-term HIV treatment.
Gilead Sciences has received mixed analyst ratings, which may result in a neutral short-term impact on its stock price. However, the strong dividend yield and positive data on Biktarvy provide a stable outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100